Patent details

EN | LT

LT - 5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUOROMETHYL)-2-PYRIDYL]AMINO]PYRAZINE-2-CARBONITRILE AND THERAPEUTIC USES THEREOF

EN - 5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUOROMETHYL)-2-PYRIDYL]AMINO]PYRAZINE-2-CARBONITRILE AND THERAPEUTIC USES THEREOF

Legal status

Patent not validated

Bibliographic data

European patent
(11)	Number of the document	2855448
(13)	Kind of document	T
(96)	European patent application number	13723910.9
	Date of filing the European patent application	2013-05-14
(97)	Date of publication of the European application	2015-04-08
(45)	Date of publication and mention of the grant of the patent	2017-02-08
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/GB2013/051233
	Date	2013-05-14

PCT application publication
(87)	Number	WO 2013/171470
	Date	2013-11-21

Priority applications
(30)	Number	Date	Country code
	201261647200 P	2012-05-15	US

Inventors
(72)	COLLINS, Ian, GB MATTHEWS, Thomas Peter, GB FARIA DA FONSECA MCHARDY, Tatiana, GB OSBORNE, James, GB LAINCHBURY, Michael, GB WALTON, Michael Ian, GB GARRETT, Michelle Dawn, GB

Grantee
(73)	Cancer Research Technology Ltd, Angel Building, 407 St John Street, London, Greater London EC1V 4AD, GB

Title
(54)	5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUOROMETHYL)-2-PYRIDYL]AMINO]PYRAZINE-2-CARBONITRILE AND THERAPEUTIC USES THEREOF
	5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUOROMETHYL)-2-PYRIDYL]AMINO]PYRAZINE-2-CARBONITRILE AND THERAPEUTIC USES THEREOF